Condition

Human Immunodeficiency Virus (HIV)

ClinicalTrials.gov condition label

Clinical trials82
Recruiting9
Common interventions25
Lead sponsors shown15

Clinical trials

60 shown
The Trans-Led Care StudyNCT06880705 · 2026-04-14
RECRUITING
HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning ClinicsNCT07089966 · 2025-12-01
RECRUITING
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)NCT07071623 · 2025-11-10
RECRUITING
Voluntary HIV Screening in the General Population in FranceNCT07418385 · 2025-10-07
RECRUITING
Reducing Systemic Inflammation in People on Antiretroviral TherapyNCT07030920 · 2025-09-30
RECRUITING
Quitting Matters Human Immunodeficiency Virus Hybrid TrialNCT06883097 · 2025-08-18
RECRUITING
Project neuroARTEMISNCT06814275 · 2025-04-29
RECRUITING
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical CareNCT06598397 · 2024-10-18
RECRUITING
Persuasive Health Communication Intervention for HIV/HCVNCT05968573 · 2023-12-04
RECRUITING
Psilocybin Therapy for Methamphetamine Use Disorder and HIVNCT07756736 · 2026-11-01
NOT_YET_RECRUITING
C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United StatesNCT07520188 · 2026-09-10
NOT_YET_RECRUITING
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)NCT07600775 · 2026-09-01
NOT_YET_RECRUITING
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIVNCT07707778 · 2026-06-25
ENROLLING_BY_INVITATION
ComBaCaL HIV Prevention TwiCsNCT07581600 · 2026-06-01
WITHDRAWN
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVNCT07576842 · 2026-06-01
NOT_YET_RECRUITING
The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIVNCT07466836 · 2026-04-11
ACTIVE_NOT_RECRUITING
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)NCT07044297 · 2025-07-31
ACTIVE_NOT_RECRUITING
Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 CountsNCT07553052 · 2025-06-01
COMPLETED
A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)NCT06783192 · 2023-08-14
COMPLETED
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose RiskNCT05657106 · 2023-03-06
ACTIVE_NOT_RECRUITING
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted InfectionsNCT05727033 · 2023-03-01
UNKNOWN
e-HERO: Ending the HIV Epidemic in Rural OklahomaNCT05664802 · 2022-12-01
COMPLETED
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy AdultsNCT05423418 · 2022-09-08
COMPLETED
A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenNCT05197075 · 2022-08-03
COMPLETED
Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)NCT04554966 · 2021-04-16
COMPLETED
Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)NCT04799353 · 2021-03-15
COMPLETED
Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in IndonesiaNCT04578145 · 2020-04-17
UNKNOWN
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1NCT04223804 · 2020-01-30
COMPLETED
POC Strategies to Improve TB Care in Advanced HIV DiseaseNCT04122404 · 2019-10-14
COMPLETED
Alcohol Monitor ValidationNCT03617705 · 2019-04-01
COMPLETED
Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy AdultsNCT03783130 · 2019-03-07
COMPLETED
Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected AdolescentsNCT03800394 · 2019-01-28
COMPLETED
Mitochondria in HIV and Aging (MITO+)NCT03489421 · 2018-12-15
COMPLETED
An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide FumarateNCT03577470 · 2018-06-13
COMPLETED
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in BordeauxNCT03290755 · 2017-11-08
COMPLETED
The Effect of Ixazomib on the Latent HIV ReservoirNCT02946047 · 2017-03-20
COMPLETED
NC Young Women's CoOpNCT02965014 · 2017-01-18
TERMINATED
Romidepsin Plus 3BNC117 Phase 2a StudyNCT02850016 · 2017-01-06
COMPLETED
An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label StudyNCT02990858 · 2016-11-03
TERMINATED
Cape Town Young Women's Health CoOpNCT02974998 · 2016-11-01
COMPLETED
New Strategies to Assess Anal Cancer Risk In WomenNCT02873741 · 2016-07-01
COMPLETED
3BNC117 and 10-1074 in HIV-infected IndividualsNCT02825797 · 2016-06-01
COMPLETED
Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in AndalusiaNCT02511496 · 2015-09-01
UNKNOWN
Tesamorelin Effects on Liver Fat and Histology in HIVNCT02196831 · 2015-07-01
COMPLETED
CPAP Improving Mortality for Pneumonia in African Children TrialNCT02484183 · 2015-06-23
TERMINATED
Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)NCT02403674 · 2015-06-05
COMPLETED
Regular HIV Testing Among At-Risk Latino MenNCT02454725 · 2015-06-01
COMPLETED
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected PatientsNCT02388594 · 2015-04-01
COMPLETED
Pericardial Fat and Inflammation in HIV Patients and ControlsNCT02399384 · 2015-01-14
COMPLETED
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure ProphylaxisNCT02165202 · 2014-10-01
COMPLETED
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive PatientsNCT02234492 · 2014-09-01
COMPLETED
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAARTNCT02225665 · 2014-08-01
COMPLETED
Intervention to Enhance PrEP Uptake and Adherence in a Community-Based SettingNCT02037594 · 2014-01-30
COMPLETED
Enhanced HIV Prevention in Couples: Feasibility Study #3NCT02027519 · 2013-12-01
COMPLETED
Assessment of Group Peer Support to Children With HIV in VietnamNCT02035969 · 2013-12-01
UNKNOWN
Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young AdultsNCT02474901 · 2013-07-01
COMPLETED
Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive AdolescentsNCT01849393 · 2013-06-01
COMPLETED
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young AdultsNCT01685372 · 2012-09-01
COMPLETED
Enhanced Prevention in Couples: Feasibility Study #2NCT02027441 · 2012-09-01
COMPLETED
Multi-level Determinants of Starting ART Late: Aim 3NCT01997359 · 2012-06-01
COMPLETED

Common interventions

PlaceboDRUG6MK-8527DRUG43BNC117DRUG2CyclophosphamideDRUG2Enhanced Treatment Support (ETS)BEHAVIORAL2ritonavirDRUG210-1074DRUG1100μg ALFQBIOLOGICAL1200μg ALFQBIOLOGICAL13% w/w SPL7013 Gel (VivaGel™)DRUG150μg ALFQBIOLOGICAL1A244BIOLOGICAL1ABBV-181DRUG1ABBV-382DRUG1Alum AdjuvantOTHER1Anal SwabsPROCEDURE1Analytical treatment interruptionOTHER1Antiretroviral (ARV) medicationsDRUG1ARTEMISBEHAVIORAL1ATRIPLA™DRUG1B.63521BIOLOGICAL1bubble continuous positive airway pressure (CPAP)DEVICE1BudigalimabDRUG1Cervical Histology (Biopsy Procedures)PROCEDURE1Cervical SwabsPROCEDURE1

Trial status mix

COMPLETED52
RECRUITING9
UNKNOWN6
NOT_YET_RECRUITING4
TERMINATED4
ACTIVE_NOT_RECRUITING3
NO_LONGER_AVAILABLE2
ENROLLING_BY_INVITATION1
WITHDRAWN1

Phase mix

NA26
PHASE115
PHASE211
PHASE47
PHASE36

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.